In addition, increased PCNA Y211 phosphorylation coincides with pronounced cell proliferation, and PCNA Y211 phosphorylation correlates better with poor survival of breast cancer patients in tumors than the total PCNA level [7]. Here, PCNA is linked to breast carcinoma.